Management of Perioperative Myocardial Infarction for Non-Cardiac Surgery

Acute Management Strategy

• The American College of Cardiology recommends that all patients with perioperative MI should receive standard medical therapy including aspirin, beta-blockers, and ACE inhibitors, regardless of whether invasive management is pursued 1, 2, 3, 4
• Aspirin should be initiated immediately and continued indefinitely unless bleeding risk is prohibitive, as recommended by the American College of Cardiology 1, 5
• Beta-blockers reduce myocardial oxygen demand through heart rate and blood pressure control, according to the American College of Cardiology 1, 5
• ACE inhibitors are especially beneficial in patients with low ejection fractions or anterior infarctions, as stated by the American College of Cardiology 1, 2, 3, 4
• High-intensity statin therapy should be initiated or continued, as recommended by the American Heart Association 6

Invasive Management Decision-Making

• The American Heart Association suggests that patients with STEMI should be considered for invasive coronary angiography (ICA), carefully balancing bleeding and thrombotic risks against the severity of clinical presentation 6
• The 2024 ACC/AHA guidelines give this a Class I recommendation, recognizing that acute coronary occlusion requires rapid intervention 6

Distinguishing MI Mechanisms

• The American College of Cardiology states that Type 1 MI (acute plaque rupture with thrombotic occlusion) should be considered for invasive management if bleeding risk permits 6, 5, 7
• The American Heart Association recommends that Type 2 MI (supply-demand mismatch) should focus on correcting underlying causes such as hypotension, tachycardia, anemia, or hypertension 6, 5, 7

Surveillance and Diagnosis

• The American Heart Association recommends that troponin measurement is mandatory in patients with signs or symptoms suggestive of myocardial ischemia or MI 8
• The American College of Cardiology states that ECG should be obtained when signs or symptoms suggest ischemia, MI, or arrhythmia 8

Long-Term Management

• The American College of Cardiology recommends that all patients who sustain perioperative MI must have left ventricular function evaluated before hospital discharge 1, 2, 3, 4, 5
• The American Heart Association states that standard postinfarction medical therapy must be prescribed as defined in ACC/AHA acute MI guidelines, including aspirin, beta-blockers, ACE inhibitors, and high-intensity statin therapy 1, 2, 3, 4

Prognostic Considerations

• The American College of Cardiology notes that perioperative MI carries extremely high mortality risk (40-70% for symptomatic MI) and substantially increases risk of future cardiac events dominated by cardiovascular death 4
• The American Heart Association states that patients presenting with perioperative MI have nearly one-third mortality or readmission rate at 30 days 6